POINT Biopharma Global Investor Relations Material
Latest events
Investor Day 2023
POINT Biopharma Global
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from POINT Biopharma Global Inc
Access all reports
POINT Biopharma Global Inc. is a radiopharmaceutical company focused on developing and commercializing radioligands for cancer treatment. The company aims to enhance precision oncology through a portfolio of targeted radioligand therapies, leveraging its in-house manufacturing capabilities and secured supplies of key medical isotopes. POINT Biopharma actively participates in clinical trials, such as the SPLASH trial for metastatic castration-resistant prostate cancer. The company is headquartered in Indianapolis, Indiana, and its shares are listed on the NASDAQ.
Latest articles
)
Verisure: Security Leader Ready for a Comeback IPO
Verisure, Europe's leading monitored alarm provider, is preparing a comeback IPO in 2025 that could be one of the year's most significant listings.
16 Sep 2025
)
Stephen J. Squeri: American Express Veteran Chairman and CEO
Stephen Squeri has spent over four decades at American Express, rising through the ranks to lead one of the world's most recognized brands.
15 Sep 2025
)
Where to? The Story of Uber
Uber's journey from rule-breaking disruptor to disciplined dual-app giant, now shaping the future of mobility, delivery, and autonomy.
5 Sep 2025
Ticker symbol
PNT
Country
🇺🇸 United States